-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Mural Oncology plc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2022 to Q3 2025.
- Mural Oncology plc Operating Income (Loss) for the quarter ending September 30, 2025 was -$3.97M, a 88.4% increase year-over-year.
- Mural Oncology plc Operating Income (Loss) for the twelve months ending September 30, 2025 was -$123M, a 23.5% increase year-over-year.
- Mural Oncology plc annual Operating Income (Loss) for 2024 was -$138M, a 29.5% increase from 2023.
- Mural Oncology plc annual Operating Income (Loss) for 2023 was -$196M, a 6.12% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)